Alterity Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ATHE and other ETFs, options, and stocks.About ATHE
Alterity Therapeutics Ltd. is a clinical stage biotechnology company. It engages in the business of research and development of therapeutic drugs designed to treat the underlying cause of degeneration of the brain focusing on Alzheimer's, Huntington, Parkinson’s, and other neurological disorders.
CEODavid A. Stamler
CEODavid A. Stamler
Employees9
Employees9
HeadquartersMelbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded1997
Founded1997
Employees9
Employees9
ATHE Key Statistics
Market cap65.25M
Market cap65.25M
Price-Earnings ratio-4.83
Price-Earnings ratio-4.83
Dividend yield—
Dividend yield—
Average volume10.54K
Average volume10.54K
High today$3.78
High today$3.78
Low today$3.57
Low today$3.57
Open price$3.78
Open price$3.78
Volume5.91K
Volume5.91K
52 Week high$7.00
52 Week high$7.00
52 Week low$1.16
52 Week low$1.16
Stock Snapshot
Alterity Therapeutics(ATHE) stock is priced at $3.63, giving the company a market capitalization of 65.25M. It carries a P/E multiple of -4.83.
On 2025-11-29, Alterity Therapeutics(ATHE) stock moved within a range of $3.57 to $3.78. With shares now at $3.63, the stock is trading +1.8% above its intraday low and -4.0% below the session's peak.
Trading activity shows a volume of 5.91K, compared to an average daily volume of 10.54K.
Over the past 52 weeks, Alterity Therapeutics(ATHE) stock has traded between a high of $7.00 and a low of $1.16.
Over the past 52 weeks, Alterity Therapeutics(ATHE) stock has traded between a high of $7.00 and a low of $1.16.